APA (7th ed.) Citation

A, B., LM, L., A, N., G, R., P, J., J, S., . . . PJ, K. (2024). Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment. Journal of neurology, 271(10), 7042. https://doi.org/10.1007/s00415-024-12661-1

Chicago Style (17th ed.) Citation

A, Balck, Lange LM, Neumann A, Royl G, Jung P, Schaumberg J, Brüggemann N, and Koch PJ. "Highly Beneficial Outcome in Severe Acute Necrotizing Encephalopathy with Tocilizumab Treatment." Journal of Neurology 271, no. 10 (2024): 7042. https://doi.org/10.1007/s00415-024-12661-1.

MLA (9th ed.) Citation

A, Balck, et al. "Highly Beneficial Outcome in Severe Acute Necrotizing Encephalopathy with Tocilizumab Treatment." Journal of Neurology, vol. 271, no. 10, 2024, p. 7042, https://doi.org/10.1007/s00415-024-12661-1.